AIMS: Our aim was to determine whether the repeated, binge administration of 3,4-methylenedioxymethamphetamine (ecstasy; MDMA) produces structural and/or functional changes in the myocardium that are associated with oxidative stress. METHODS AND RESULTS: Echocardiography and pressure-volume conductance catheters were used to assess left ventricular (LV) structure and function in rats subjected to four ecstasy binges (9 mg/kg i.v. for 4 days, separated by a 10 day drug-free period). Hearts from treated and control rats were used for either biochemical and proteomic analysis or the isolation of adult LV myocytes. After the fourth binge, treated hearts showed eccentric LV dilation and diastolic dysfunction. Systolic function was not altered in vivo; however, the magnitude of the contractile responses to electrical stimulation was significantly smaller in myocytes from rats treated in vivo with ecstasy compared with myocytes from control rats. The magnitude of the peak increase in intracellular calcium (measured by Fura-2) was also significantly smaller in myocytes from ecstasy-treated vs. control rats. The relaxation kinetics of the intracellular calcium transients were significantly longer in myocytes from ecstasy-treated rats. Ecstasy significantly increased nitrotyrosine content in the left ventricle. Proteomic analysis revealed increased nitration of contractile proteins (troponin-T, tropomyosin alpha-1 chain, myosin light polypeptide, and myosin regulatory light chain), mitochondrial proteins (Ub-cytochrome-c reductase and ATP synthase), and sarcoplasmic reticulum calcium ATPase. CONCLUSION: The repeated binge administration of ecstasy produces eccentric LV dilation and dysfunction that is accompanied by oxidative stress. These functional responses may result from the redox modification of proteins involved in excitation-contraction coupling and/or mitochondrial energy production. Together, these results indicate that ecstasy has the potential to produce serious cardiac toxicity and ventricular dysfunction.
AIMS: Our aim was to determine whether the repeated, binge administration of 3,4-methylenedioxymethamphetamine (ecstasy; MDMA) produces structural and/or functional changes in the myocardium that are associated with oxidative stress. METHODS AND RESULTS: Echocardiography and pressure-volume conductance catheters were used to assess left ventricular (LV) structure and function in rats subjected to four ecstasy binges (9 mg/kg i.v. for 4 days, separated by a 10 day drug-free period). Hearts from treated and control rats were used for either biochemical and proteomic analysis or the isolation of adult LV myocytes. After the fourth binge, treated hearts showed eccentric LV dilation and diastolic dysfunction. Systolic function was not altered in vivo; however, the magnitude of the contractile responses to electrical stimulation was significantly smaller in myocytes from rats treated in vivo with ecstasy compared with myocytes from control rats. The magnitude of the peak increase in intracellular calcium (measured by Fura-2) was also significantly smaller in myocytes from ecstasy-treated vs. control rats. The relaxation kinetics of the intracellular calcium transients were significantly longer in myocytes from ecstasy-treated rats. Ecstasy significantly increased nitrotyrosine content in the left ventricle. Proteomic analysis revealed increased nitration of contractile proteins (troponin-T, tropomyosin alpha-1 chain, myosin light polypeptide, and myosin regulatory light chain), mitochondrial proteins (Ub-cytochrome-c reductase and ATP synthase), and sarcoplasmic reticulum calcium ATPase. CONCLUSION: The repeated binge administration of ecstasy produces eccentric LV dilation and dysfunction that is accompanied by oxidative stress. These functional responses may result from the redox modification of proteins involved in excitation-contraction coupling and/or mitochondrial energy production. Together, these results indicate that ecstasy has the potential to produce serious cardiac toxicity and ventricular dysfunction.
Authors: Emily C Rothstein; Kenneth L Byron; Ryan E Reed; Larry Fliegel; Pamela A Lucchesi Journal: Am J Physiol Heart Circ Physiol Date: 2002-08 Impact factor: 4.733
Authors: Lisa A Badon; Alissa Hicks; Kevin Lord; Brian A Ogden; Suzanne Meleg-Smith; Kurt J Varner Journal: J Pharmacol Exp Ther Date: 2002-09 Impact factor: 4.030
Authors: Christopher A Koczor; Ivan Ludlow; Robert S Hight; Zhe Jiao; Earl Fields; Tomika Ludaway; Rodney Russ; Rebecca A Torres; William Lewis Journal: Toxicol Sci Date: 2015-08-06 Impact factor: 4.849
Authors: Lucienne S Lara; Michael McCormack; Laura C Semprum-Prieto; Sylvia Shenouda; Dewan S A Majid; Hiroyuki Kobori; L Gabriel Navar; Minolfa C Prieto Journal: Am J Physiol Renal Physiol Date: 2011-09-07
Authors: Kevin Lord; David Moll; John K Lindsey; Sarah Mahne; Girija Raman; Tammy Dugas; Stephania Cormier; Dana Troxlair; Slawo Lomnicki; Barry Dellinger; Kurt Varner Journal: J Recept Signal Transduct Res Date: 2011-04 Impact factor: 2.092
Authors: Kevin C Lord; Sylvia K Shenouda; Elizabeth McIlwain; Dimitrios Charalampidis; Pamela A Lucchesi; Kurt J Varner Journal: Cardiovasc Res Date: 2010-02-05 Impact factor: 10.787
Authors: Ge Tao; Agata K Levay; Jacqueline D Peacock; Danielle J Huk; Sarah N Both; Nicole H Purcell; Jose R Pinto; Maarten L Galantowicz; Manuel Koch; Pamela A Lucchesi; David E Birk; Joy Lincoln Journal: J Mol Cell Cardiol Date: 2012-08-11 Impact factor: 5.000